Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the detailed record of transactions filed by Lui Alfred Fu Kong, Director. Officer active across 1 company, notably Emmaus Life Sciences, Inc.. Cumulatively, 1 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Alfred Fu Kong Lui serves as a Director at Emmaus Life Sciences, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the life sciences sector is a valuable asset for the board. He is committed to supporting Emmaus in its growth and innovation initiatives.